Albumin has seen a recent resurgence due to the positive results seen in the RELIEF study where albumin dialysis was used via the molecular adsorbent recirculating system (MARS) to treat 189 patients with acute on chronic liver failure. This evidence concerns the gene ALB and chronic liver failure.